$35.85−0.47 (−1.28%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE Arca · USD
iShares Health Innovation Active ETF (BMED) Expense Ratio
Sources Fund holdings disclosures Fund disclosuresHow we compute thisNot investment advice
A 0.77% expense ratio sounds abstract. Here's what it is versus its Growth peers, and what any fee actually costs you in real dollars over time.
Expense ratio vs category
0.77%$77 per $10,000/yr
BMED0.77%
Category avg0.55%
Peer set: US-listed Growth equity ETFs · fee point-in-time.
Fee-drag calculator · in dollars
Amount invested
Holding period
BMED fee cost (0.77%)$13,012
If it charged category avg (0.55%)$9,502
Extra cost vs category average$3,510
$3,510 more than a category-average fund would cost over this period.
Fee dollars over 20 years on $25,000, assuming 7%/yr growth. Dollarising the fee is what actually changes behaviour.

